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DOI 10.1186/s12906-015-0724-2RESEARCH ARTICLE Open AccessAntinociceptive effects of hydroalcoholic
extract from Euterpe oleracea Mart. (Açaí) in a
rodent model of acute and neuropathic pain
Roberto T. Sudo1*, Miguel L. Neto2, Carlos E.S. Monteiro1, Rachel V. Amaral1, Ângela C. Resende2,
Pergentino J.C. Souza3, Gisele Zapata-Sudo1 and Roberto S. Moura2Abstract
Background: Plants rich in flavonoids, such as açaí (Euterpe oleraceae Mart.), can induce antinociception in experimental
animals. Here, we tested an extract obtained from the stones of açaí fruits (açaí stone extract, ASE), a native plant from
the Amazon region of Brazil, in models of acute/inflammatory and chronic pain.
Methods: Antinociceptive effects of ASE were evaluated in the hot plate, formalin, acetic acid writhing, carrageenan, and
neuropathic pain models, as well as in thermal hyperalgesia and mechanical allodynia models induced by spinal nerve
ligation. Antinociceptive activities were modulated by the administration of cholinergic, adrenergic, opioid, and
L-arginine-NO antagonists.
Results: Oral administration of ASE (30, 100, or 300 mg.kg−1) dose-dependently reduced nociceptive responses to
acute/inflammatory pain in mice, including thermal hyperalgesia, acetic acid-induced writhing, and carrageenan-induced
thermal hyperalgesia. Moreover, ASE reduced the neurogenic and inflammatory phases after intraplantar injection
of formalin in mice. The antinociceptive effect of ASE (100 mg · kg−1) in a hot plate protocol, was inhibited by
pre-treatment with naloxone (1 mg · kg−1), atropine (2 mg · kg−1), yohimbine (5 mg · kg−1), or L-NAME (30 mg · kg−1).
Furthermore, ASE prevented chronic pain in a rat spinal nerve ligation model, including thermal hyperalgesia and
mechanical allodynia.
Conclusion: ASE showed significant antinociceptive effect via a multifactorial mechanism of action, indicating that the
extract may be useful in the development of new analgesic drugs.








Pain can reduce normal activities and negatively impact
quality of life. Current options for the pharmacological
treatment of pain include non-steroidal anti-inflammatory
drugs and opioids, which unfortunately cause several side
effects. The biodiversity present in countries like Brazil
represents a potentially important source for development
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creativecommons.org/publicdomain/zero/1.0/Euterpe oleracea Mart., popularly known as “açaí”, be-
longs to the family Arecaceae and is widely distributed
in the Amazon region of Brazil. The fruit is an important
source of food and is used as a medicinal plant for fever,
pain, inflammation and anemia treatment [2].
Açaí fruits are rich in anthocyanic compounds (cyani-
din 3-O-rutinoside) and other polyphenols, such as epi-
catechine, catechine homoorientin, orientin, isovitexin,
and taxifolin deoxyhexose [3, 4], which have important
biological effects.
Previously, we demonstrated that the hydro-alcoholic
extracted from açaí stones (açaí stone extract, ASE), which
is rich in polymeric proanthocyanidins, have important
vasodilatory [5], antihypertensive [6], antioxidant [7], and
anti-inflammatory [8] activities. As extracts from plantsicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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we tested the effects of ASE in acute and chronic models








































E. oleracea Mart. fruits (açaí) were obtained from Ama-
zon Bay (Belém do Pará, Brazil; excicata number 29052,
Museu Goeldi-Belem do Pará). Hydro-alcoholic extracts
were obtained from a decoction of the seeds of the fruits
as previously described by Moura et al. [8]. Briefly, 200 g
of açaí stone were boiled in 400 ml of distilled water for
5 min, mixed for 2 min, and then boiled again for 5 min.
The decoction was cooled to room temperature and
extracted by addition of 400 ml of ethanol with shaking
for 2 h. The extract was stored in dark bottles inside a re-
frigerator (4 °C) for 10 days. After this maceration period,
hydroalcoholic extracts of açaí were filtered through
Whatman filter paper. Ethanol was evaporated by using a
rotary evaporator (Fisatom Equipamentos Científicos Ltda
São Paulo, São Paulo, Brazil) under low pressure at 55 °C.
The extract was lyophilized (LIOTOP model 202, Fisatom
Equipamentos Científicos Ltda São Paulo) at temperatures
from −30 to −40 °C and under a vacuum of 200 mmHg,
and frozen at −20 °C, until use. Typically, 100 g of stone
yielded approximately 5 g of lyophilized extract.
ASE was analyzed on an RP-18 column (250 mm ×
4 mm, 5 μm particles) according to a procedure re-
ported by Peng et al. [11]. Elution was conducted with
solvents A (0.2 % v/v phosphoric acid) and B (82 % v/v
acetonitrile, 0.04 % v/v phosphoric acid) at a flow rate
of 1 ml.min−1. Ultraviolet–visible (UV–vis)-DAD ab-
sorption spectra were recorded on-line during High-
Performance Liquid Chromatography (HPLC) analysis.
The HPLC elution profile of ASE can indicate the
presence of proanthocyanidins [11]. The peak eluting at
37.2 min corresponded to catechin, as confirmed by
co-injection of a standard and by comparison of the
UV absorption spectra. The late elution (at 54.7 min)
and UV spectrum of the main peak are consistent with









151Animals and housing conditions
Male Swiss mice (18–25 g) and male Wistar rats (180–
220 g), obtained from Vital Brasil Institute and the
Federal University of Rio de Janeiro, respectively, were
housed under a 12 h light–dark cycle at 21 °C and 60 %
humidity, with food and water ad libitum. Protocols
were reviewed and approved by the institutional Animal
Care and Use Committee (CEUA, Ref. #DFBCICB061).Drugs
Atropine, carrageenan, acetylsalicylic acid, indometh-
acin, formaldehyde and L-nitro arginine methyl ester
(L-NAME) were purchased from Sigma (St Louis, MO,
USA). Yohimbine hydrochloride was purchased from
Tocris (Ellisville, MO, USA). Tramadol, naloxone, ami-
triptyline hydrochloride and morphine sulfate were do-
nated by Cristália Produtos Químicos e Farmacêuticos
Ltda (Itapira, SP, Brazil). ASE was dissolved in distilled
water (10 mg.ml−1, stock solution).
Hot plate test
The hot plate test in mice [12] was used to test the effect
of orally administered ASE (30, 100 or 300 mg.kg−1) on
pain responses mediated by the central nervous system
(CNS). Oral tramadol (2 mg.kg−1) was used as a positive
control. Withdrawal latency (reaction time of the animal
when placed on a surface heated to 52 °C) was measured
before and 30 min after oral administration of either saline
tramadol (2 mg.kg−1) or ASE (30, 100 or 300 mg.kg−1).
Additional measurements were performed every 15 min
up to 120 min to determine the maximum possible effect
(%MPE), which occurred 20–25 min after ASE adminis-
tration. Analgesic activity was calculated as the %MPE by
using the formula: %MPE = [(latency observed) – (latency
control) x 100] / [(cut-off) – (latency control)] (Fig. 1).
To investigate the possible mechanisms involved in
ASE activity animals received pre-administration of the
following antagonists: 30 mg.kg−1 Nω-nitro-L-arginine
methyl ester (L-NAME, selective NOS inhibitor),
1 mg.kg−1 naloxone (opioid antagonist), 2 mg.kg−1 atro-
pine (muscarinic antagonist), or 5 mg.kg−1 yohimbine
(α−2 adrenoceptor antagonist). A 100 mg.kg
−1 dose of
ASE, produced a MPE of 50 % and was used for the
mechanism of action experiments.
Formalin-induced hind paw-licking
The antinociceptive effect of ASE on neurogenic and
inflammatory pain was tested by using the formalin test
in mice [13]. Formalin (2.5 %, 20 μl) was administered
by intraplantar injection into the right hind paw 15 min
after oral administration of saline, acetylsalicylic acid
(150 mg. kg−1), morphine sulfate (30 mg.kg−1) or ASE
(30, 100, or 300 mg.kg−1). The duration of licking and
biting of the injected paw was monitored over 0–5 min
(early phase, neurogenic pain response) and 15–30 min
(late phase, inflammatory pain response).
Carrageenan-induced pain
Carrageenan-induced thermal hyperalgesia was evalu-
ated in mice as described [12, 14]. Animals were placed
in transparent boxes on a glass surface, and a radiant
heat stimulus was applied through the glass onto the










































































ASE + L-NAME 30 mg.kg-1
ASE + naloxone 1 mg.kg-1
ASE + atropine 2 mg.kg-1














Fig. 1 a Effect of ASE (30, 100 and 300 mg.kg−1, p.o.) and tramadol (2 mg.kg−1, p.o) in the hot plate test, b Evaluation of mechanism of action of
ASE. The bars represent the mean ± SEM (n = 10). *P < 0.05 versus saline, #P < 0.05 versus ASE group. ANOVA followed by Newman-Keuls test
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Peripheral inflammation was induced by intraplantar in-
jection of carrageenan (1 %, 20 μl) into the right hind
paw at time zero. The latency of each animal to react to
the thermal stimulus was measured at different time
points before (control measure) and after carrageenan
injection. Saline, acetylsalicylic acid (150 mg.kg−1), or
ASE (30, 100, or 300 mg.kg−1) was administered orally
15 min before carrageenan. A cut-off time of 15 s was











Mice received intraperitoneally (i.p.) administered acetic
acid (0.6 %, 10 μl.g−1 v/v), as previously reported [15],
and were placed in a box (40 x 30 x 25 cm) in a quiet, il-
luminated room. The resulting abdominal contortions
(writhes) were counted for 20 min, beginning 10 min
after acetic acid administration, as previously described
[16]. Saline, the reference drug indomethacin (2 mg.kg
−1) or ASE (30, 100, or 300 mg.kg−1) was administered










213Spinal nerve ligation (SNL)
Neuropathic pain signs (thermal hyperalgesia and mech-
anical allodynia) were induced by SNL as described [17].
Briefly, after anesthesia with ketamine (100 mg.kg−1 i.p.)
and xylazine (5 mg.kg−1 i.p.), Wistar rats (180–220 g),
were placed in the prone position. The right L5 spinal
nerve was isolated and tightly ligated with 6.0 silk
threads. After the procedure, the wound was sutured.
Animals were individually housed after surgery for the
remainder of the study.Antinociceptive effect on SNL-induced thermal hyperalgesia
and mechanical allodynia
Thermal hyperalgesia was assessed using latency of paw
withdraw [14, 18] from a radiant heat source applied to
the plantar surface of the hind paws. Animals were
placed in transparent acrylic boxes for 20–30 min to
acclimatize before application of radiant heat through
the glass flooring. Latency from stimulus onset to paw
withdrawal was measured across three trials with a cut-
off of 30 s.
Mechanical allodynia was assessed by using a digital
version of the Von Frey filaments [18]. Rats were placed
in individual acrylic boxes for 30 min to acclimatize.
Stimuli were applied to the plantar region of the hind
paw, and the withdrawal threshold was assessed across
five trials with a cutoff of 120 g. Control measurements
were taken before and 7 days after SNL. Rats were sub-
jected to thermal hyperalgesia and mechanical allodynia
tests to confirm the success of SNL surgery and the on-
set of neuropathic pain. After daily treatment with ASE
for 7 days, pain tests were repeated.Statistical analysis
Data are reported as the mean ± standard error of the mean
(S.E.M.). One-way ANOVA followed by the Newman-Keuls
test was used to analyze the effects of ASE on the hot
plate test, formalin-induced pain, and acetic acid-
induced writhing. Two-way ANOVA followed by the
Bonferroni post-hoc test was used to analyze the effects
of ASE on the carragenin-induced pain and on the SNL
experiments. Data were graphed and statistically ana-
lyzed by using GraphPad Prism 5.0. Differences were













































































































Fig. 2 Effect of ASE and acetylsalicylic acid on the formalin test. The
bars represent mean ± SEM (n = 10). *P < 0.05 versus saline. ANOVA
followed by Newman-Keuls test
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Hot plate test
Treatment with 30, 100, or 300 mg.kg-1 ASE dose-
dependently increased the %MPE to 39.1 ± 10.0, 51.9 ± 9.5,
or 94.7 ± 4.4 %, respectively (Fig. 1a, n = 10 per group,
p < 0.05). The %MPE was also increased by tramadol
(2 mg.kg−1) to 78.3 ± 10.3 % (n = 10, p < 0.05). Pre-
treatment with i.p. administration of L-NAME (30 mg.kg
−1), naloxone (1 mg.kg−1), yohimbine (5 mg.kg−1) or atro-
pine (2 mg.kg−1) reduced the antinociceptive effect of ASE
(100 mg.kg−1) from 51.9 ± 9.5 to 8.9 ± 3.3, 8.3 ± 3.3, 13.6 ±
4.1, or 26.2 ± 6.8 %, respectively (Fig. 1b, n = 10 per group,
p < 0.05).
Nociception induced by thermal stimulation (hot plate
test) is used to evaluate antinociceptive agents that act
centrally but not peripherally [19]. This test involves vari-
ous physiological systems, including cholinergic, adrener-
gic, opioid, and L-arginine/NO, which may be targets for
antinociceptive compounds.
The importance of the sympathetic nervous system in
pain modulation has been known since 1904, when Weber
[20] demonstrated the antinociceptive effect of epineph-
rine injected in the spinal cord of a cat. Intrathecal or
intraperitoneal administration of α2-adrenoceptor agonists
induces significant antinociceptive effects in the hot plate
test in rodents [21]. Here, the α2-adrenoceptor antagonist
yohimbine inhibited the antinociceptive effect of ASE,
supporting involvement of the adrenergic system on pain
modulation, consistent with others flavonoids [22]. The
antinociceptive effect of ASE is probably dependent on
flavonoids content, because flavones [23], and quercetine
[24] have similar effect in animals. Specifically, polymeric
proanthocyanidins, which are common compounds in
our extract, may underlie the antinociceptive effects, as
seem with proanthocyanidins obtained from Croton
celtidifolius bark [9].
Morphine is considered to be the gold standard drug
for systemic pain treatment. However, prolonged use of
morphine induces tolerance and hyperalgesia. In the
present study naloxone, an opioid antagonist blocked
the anti-nociceptive effects of ASE. Opioid mechanisms
also modulate the antinociceptive effects of flavones
compounds [23] and quercetin [22]. Muscarinic cholin-
ergic receptors are present along the pain pathway
from the dorsal root ganglia to somatosensory cortex
[25], and muscarinic agonists have antinociceptive
effects in rodents [18]. Inhibition of muscarinic recep-
tors by atropine reduced, but did not abolish the anti-
nociceptive effect of ASE. This finding suggests that
cholinergic mechanisms may mediate these activities.
The L-arginine–nitric oxide (NO)/cyclic guanosine
monophosphate (cGMP) pathway also modulate pain
responses [26]. NO activates soluble guanylyl cyclase,
leading to the production of cGMPn which activatescGMP-dependent protein kinase to open ATP-sensitive
K+ channels, leading to neuronal hyperpolarization and
spinal and peripheral antinociception [27]. In this study,
the NO synthesis inhibitor L-NAME inhibited the anti-
nociceptive effect of ASE. This inhibition demonstrates
the involvement of the L-arginine-NO-pathway to the
antinociceptive activities of ASE. Inhibition of NO syn-
thesis antagonizes the activities of several antinociceptive
compounds [28].
Taken together, these results indicate that ASE has an
antinociceptive effect that is modulated by the choliner-
gic, adrenergic, opioid, and L-arginine-NO pathways. In
addition, reactive oxygen species can enhance nocicep-
tive responses [29], and ASE may block these responses
via antioxidant activities and increasing NO-synthase to
release NO [30].
Formalin-induced hind paw-licking test
The total amounts of time spent licking, scratching, or
biting during the neurogenic and inflammatory phases
after intraplantar injection of formalin were 73.1 ± 6.1 s
and 207.8 ± 19.0 s, respectively (Fig. 2). Reactivity in the
neurogenic phase was not affected by oral administra-
tion of the lowest doses of ASE (30 mg.kg−1) or acetyl-
salicylic acid (150 mg.kg−1), but was reduced by higher




















































































Sudo et al. BMC Complementary and Alternative Medicine  (2015) 15:208 Page 5 of 836.4 ± 5.3 s, respectively (p < 0.05). Reactivity in the
inflammatory phase was reduced by acetylsalicylic acid to
101.9 ± 14.9 s and by (30, 100, or 300 mg.kg−1 ASE) to
122.5 ± 14.5 s, 90.1 ± 15.2 s and 106.4 ± 11.0 s, respectively
( p < 0.05).
Intraplantar injection of formalin in rodents induces
nociceptive-related behavior when assessed over two
temporally distinct phases [13]. The first phase is induced
by a direct activation of peripheral afferent C-fibers. The
second phase is mediated by ongoing stimulation of noci-
ceptors by inflammatory mediators (serotonin, histamine,
bradykinin, NO, and prostaglandins) released from injured
tissue, leading to activity-dependent sensitization of CNS
neurons within the dorsal horn [31]. Local anesthetics and
morphine inhibit the first phase whereas NSAIDs in-
hibit the second inflammatory phase. In this study, we
found that ASE inhibited the first phase, probably due to
interaction with CNS targets. ASE reduced reactivity in
the second phase; this finding suggests that ASE has anti-
inflammatory activities, perhaps via inhibition of cyclooxy-

















Fig. 3 Effect anti-hyperalgesic of ASE and acetylsalicylic acid on
the carrageenan test. The points represent the mean ± SEM (n = 10).
*P < 0.05 versus saline. Two-way ANOVA followed by Bonferroni post
hoc testCarrageenan-induced pain test
Intraplantar administration of carrageenan reduced paw
withdrawal latency to heat stimulation to 55.4 ± 5.7 % of
control (Fig. 3). The effect of carrageenan was noted
5 min after administration, sustained for 150 min, and not
affected by oral administration of ASE (30 mg.kg−1).
However, higher doses of ASE (100 and 300 mg.kg−1) or
acetylsalicylic acid (150 mg.kg−1) reduced the effect of car-
rageenan on paw withdrawal latency.
After carrageenan-induced inflammation, noxious stim-
uli elicit an enhanced pain response (hyperalgesia) [14].
This enhanced synaptic transmission is essential for central
sensitization. ASE prevented the appearance of this
sensitization, supporting its antinociceptive effects in
inflammatory pain. Some flavonoids in açaí are modu-
late proinflammatory cytokine production [32]. Carra-
geenan stimulates the release of tissue necrosis factor
(TNF)-α, interleukin (IL)-1β and IL-6, with subsequent
increases in COX products and IL-8, to stimulate local
production of sympathetic amines [33]. Therefore, ASE
may block the cascade of cytokine release induced by








365Acetic acid-induced writhing test
ASE at 100 and 300 mg.kg−1 dose-dependently reduced
the number of abdominal contractions in response to
acetic acid from 61.0 ± 4.8 (saline) to 44.5 ± 4.2 and 26.9 ±
2.5, respectively (p < 0.05). This effect was not significant
at the lowest dose of ASE (30 mg.kg−1), which slightlyreduced contractions to 50.5 ± 4.4. The reference drug
indomethacin (2 mg.kg−1) reduced contractions to 34.4 ±
5.1 (Fig. 4).
The acetic acid-induced writhing test is a screening tool
for assessment of antinociceptive and anti-inflammatory
agents [34]. Intraperitoneal injection of acetic acid in-
creases pain mediators, such as prostaglandins, lipoxygen-
ase, cyclooxygenase, histamine, serotonin, bradykinin,
substance P, IL-1β, IL-8, and TNF-α [34, 35], which
increase vascular permeability and reduce the nociceptive
threshold, causing stimulation of nociceptive terminals to
induce abdominal writhing. The writhing response starts a
few minutes after acetic acid injection. Reduction of this
behavior is used to test the efficacy of drugs with visceral
antinociceptive activity [36]. We measured the writhing
response for 20 min starting 10 min after acetic acid injec-
tion to avoid counting stress reaction of the animal due to
manipulation. We found similar writhing levels to other
studies that measured the reaction for 30 min starting
5 min after acetic acid administration [16, 37]. Pre-
treatment with ASE reduced the acetic acid-induced writh-



























































Fig. 4 Effect of ASE and indomethacin on the acetic acid-induced
writhing test. The number of writhing was evaluated during 30 minutes.
The bars represent the mean ± SEM (n = 10). *P < 0.05 versus saline.
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Fig. 5 Antinociceptive effect of ASE or amitriptyline in SNL rats. The ASE an
a) Latency in response to thermal stimulation and b) Withdrawal threshold
submitted to SNL. The points represent the mean ± SEM (n = 4). *P < 0.05 vers
post hoc test
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ASE (10, 30, or 100 mg.kg−1) dose-dependently prevented
development of thermal hyperalgesia and mechanical allo-
dynia in SNL rats on the ipsilateral side (Fig 5a and b), but
no effect was observed on the contralateral side. At 7 days
after surgery, the thermal withdrawal duration was re-
duced from 13.6 ± 0.5 s to 7.4 ± 0.9 s (n = 4). ASE had
significant effects from day 1 to 7 of treatment, reaching
13.2 ± 0.4 s. Treatment with 10 or 30 mg.kg−1 ASE was as
effective as 10 mg.kg−1 amitriptyline. The mechanical with-
drawal threshold was reduced 7 days after surgery from
40.5 ± 0.6 g to 18.8 ± 1.0 g. After 7 days of treatment, ASE
(100 mg.kg−1, n = 4) increased this threshold to 32.9 ±
3.2 g, similar to amitriptyline (10 mg.kg−1, n = 4). ASE had
no effect on withdrawal duration or withdrawal threshold
in the contralateral paw (Fig. 5).
Chronic pain with neuropathic features affects 7-8 %
of the general population [38]. Unfortunately, current
pharmacotherapies used to treat the main symptoms of
this disorder, hyperalgesia and allodynia, are not com-
pletely effective. Oral administration of ASE over 7 days
prevented the development of thermal hyperalgesia and
mechanical allodynia in rats with SNL. Analgesic effects
of ASE in this model were observed from 1 to 7 days
after treatment with no signs of tolerance, which is a
drawback of morphine [39]. Furthermore, side effects
such as sedation were not observed after prolonged ASE
treatment, providing an advantage over amitriptyline,
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d amitriptyline were once daily administered by gavage during 7 days.
in response to mechanical stimulation applied to the paw of rats
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the antinociceptive effects in rats subjected to SNL.
Flavonoids such as the polyphenolic compounds rutin
and quercetin have anti-inflammatory [41], analgesic
[42], and antioxidant [43] effects. SNL is a neuropathic
pain model used in rats that mimics the pain sensations
experienced by human patients [44]. ASE had compar-
able efficacy to the clinical drug amitriptyline, in treating
SNL-induced neuropathic pain. Others flavonoids can
impact animal models of neuropathic pain. For example,
Azevedo et al. [24] showed that rutin and quercetin pre-
vented thermal and mechanical nociceptive responses in
oxaliplatin-induced neuropathic pain in mice by mediat-
ing oxidative stress-induced damage.
Conclusions
The present study demonstrates a significant and potent
antinociceptive effect of oral ASE. The mechanism of this
antinociceptive effect is not completely understood, but
probably involves various pathophysiological systems.
These findings indicate the possibility for development of
a new analgesic drug.
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